20240016487. INTERSEPTAL OCCLUDER DEVICE simplified abstract (Recross Cardio Inc.)

From WikiPatents
Jump to navigation Jump to search

INTERSEPTAL OCCLUDER DEVICE

Organization Name

Recross Cardio Inc.

Inventor(s)

Giovanni Rolando of Dover DE (US)

Thomas Gerhardt of Cape Town (ZA)

Marco Ferrone of Dover DE (US)

Gilberto Melnick of Dover DE (US)

INTERSEPTAL OCCLUDER DEVICE - A simplified explanation of the abstract

This abstract first appeared for US patent application 20240016487 titled 'INTERSEPTAL OCCLUDER DEVICE

Simplified Explanation

The present invention is an occluder device comprising a supporting structure with a central portion, distal branches, and proximal branches. The branches have elastic hooked struts that can rotate to anchor a septum of a heart. The occluder device also includes at least one membrane connected to the branches, which can be deformed to create a passage for an external device.

  • The invention is an occluder device used for closing septal defects in the heart.
  • The device includes a supporting structure with a central portion, distal branches, and proximal branches.
  • The distal and proximal branches have elastic hooked struts that can rotate to anchor the device to the septum of the heart.
  • The device also includes at least one membrane connected to the branches.
  • The membrane has a closed position when the branches are unfolded or lying, providing maximum occlusion to the supporting structure.
  • The membrane has at least one slit that can be deformed by an external device, creating a passage for the device.

Potential applications of this technology:

  • Closing septal defects in the heart, such as atrial septal defects or ventricular septal defects.
  • Minimally invasive heart surgeries.
  • Cardiac catheterization procedures.

Problems solved by this technology:

  • Provides a less invasive alternative to traditional surgical methods for closing septal defects.
  • Allows for precise and controlled closure of the defect.
  • Reduces the risk of complications associated with open-heart surgery.

Benefits of this technology:

  • Minimally invasive procedure, resulting in shorter recovery time and reduced hospital stay.
  • Precise and controlled closure of the septal defect.
  • Reduced risk of complications compared to open-heart surgery.
  • Potential for improved patient outcomes and quality of life.


Original Abstract Submitted

the present invention relates to an occluder device () comprising a supporting structure () said supporting structure () comprising a central portion () having a distal end () and a proximal end (); said supporting structure () comprising distal branches () extending away from said distal end () of the central portion (); said supporting structure () comprising proximal branches () extending away from said proximal end () of the central portion (); said proximal and distal branches () defining elastic hooked struts which are rotatable away from the central portion () to anchor a septum () of a heart (); said occluder device () further comprising at least one membrane (); said membrane () comprises a membrane body () connected to the distal or proximal branches (); when the branches () are in the unfolded or lying position, said membrane () has a closed position where the membrane () is in a configuration which provides maximum occlusion to the supporting structure (); wherein said membrane () comprises at least one slit (); which, when actively engaged by an external device () the membrane () deforms the slit () which extends elastically, creating a passage lumen () for said external device ().